Unknown

Dataset Information

0

SA4503, A Potent Sigma-1 Receptor Ligand, Ameliorates Synaptic Abnormalities and Cognitive Dysfunction in a Mouse Model of ATR-X Syndrome.


ABSTRACT: ?-thalassemia X-linked intellectual disability (ATR-X) syndrome is caused by mutations in ATRX. An ATR-X model mouse lacking Atrx exon 2 displays phenotypes that resemble symptoms in the human intellectual disability: cognitive defects and abnormal dendritic spine formation. We herein target activation of sigma-1 receptor (Sig-1R) that can induce potent neuroprotective and neuroregenerative effects by promoting the activity of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF). We demonstrated that treatment with SA4503, a potent activator of Sig-1R, reverses axonal development and dendritic spine abnormalities in cultured cortical neurons from ATR-X model mice. Moreover, the SA4503 treatment rescued cognitive deficits exhibited by the ATR-X model mice. We further found that significant decreases in the BDNF-protein level in the medial prefrontal cortex of ATR-X model mice were recovered with treatment of SA4503. These results indicate that the rescue of dendritic spine abnormalities through the activation of Sig-1R has a potential for post-diagnostic therapy in ATR-X syndrome.

SUBMITTER: Yamaguchi K 

PROVIDER: S-EPMC6163584 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

SA4503, A Potent Sigma-1 Receptor Ligand, Ameliorates Synaptic Abnormalities and Cognitive Dysfunction in a Mouse Model of ATR-X Syndrome.

Yamaguchi Kouya K   Shioda Norifumi N   Yabuki Yasushi Y   Zhang Chen C   Han Feng F   Fukunaga Kohji K  

International journal of molecular sciences 20180918 9


α-thalassemia X-linked intellectual disability (ATR-X) syndrome is caused by mutations in <i>ATRX</i>. An ATR-X model mouse lacking <i>Atrx</i> exon 2 displays phenotypes that resemble symptoms in the human intellectual disability: cognitive defects and abnormal dendritic spine formation. We herein target activation of sigma-1 receptor (Sig-1R) that can induce potent neuroprotective and neuroregenerative effects by promoting the activity of neurotrophic factors, such as brain-derived neurotrophi  ...[more]

Similar Datasets

| S-EPMC3038768 | biostudies-literature
| S-EPMC3004537 | biostudies-literature
| S-EPMC7244039 | biostudies-literature
| S-EPMC5374488 | biostudies-literature
| S-EPMC8652290 | biostudies-literature
| S-EPMC6704709 | biostudies-literature
| S-EPMC8299468 | biostudies-literature
| S-EPMC3448741 | biostudies-literature
| S-EPMC6128908 | biostudies-literature
| S-EPMC5459814 | biostudies-literature